HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,471 shares of the company’s stock after selling 3,413 shares during the quarter. MetLife Investment Management LLC’s holdings in HCA Healthcare were worth $20,513,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. FMR LLC lifted its stake in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after acquiring an additional 2,397,883 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $131,527,000. Darsana Capital Partners LP lifted its holdings in HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares in the last quarter. Swedbank AB acquired a new position in shares of HCA Healthcare in the first quarter worth $95,882,000. Finally, Argent Capital Management LLC raised its position in HCA Healthcare by 1,215.6% in the 2nd quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock valued at $51,493,000 after purchasing an additional 148,092 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,155 shares of company stock valued at $5,608,990. Insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent analyst reports. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. UBS Group raised their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Finally, Barclays decreased their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $380.29.

HCA Healthcare Stock Performance

Shares of HCA opened at $325.35 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The company has a 50-day simple moving average of $374.98 and a 200-day simple moving average of $358.51. HCA Healthcare, Inc. has a 52-week low of $245.84 and a 52-week high of $417.14. The company has a market capitalization of $82.41 billion, a PE ratio of 14.61, a P/E/G ratio of 1.25 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.81%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.